The heat of the summer season brings a few more challenges for children living with diabetes. An expert speaks about how the ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly expanded our margin profiles, and continued to advance key programs through our ...

What’s worse, an additional 3 million adults with diabetes in the U.S. never receive a diagnosis, let alone necessary care. 4 ...

“This is a win for people with diabetes, offering more people world-leading Libre technology,” said Jared Watkin, executive vice president of Abbott’s diabetes care business, in a statement.

Jared Watkin, senior vice president of Abbott’s diabetes care unit, agreed with Brewer’s assertions. He pointed out that Abbott’s FreeStyle Libre portfolio is the most widely used and ...

The company revolutionized diabetes care 10 years ago with its world-leading Libre continuous glucose monitoring portfolio, which today is used by 7 million people in more than 60 countries. 4 ...

Shares of Abbott (ABT) fell a steep 7% on Thursday morning after the company’s third-quarter earnings guidance disappointed investors. For full-year 2025, Abbott expects adjusted diluted earnings per ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Abbott diabetes care business chief medical officer Mahmood Kazemi said: "These data are transformative and show just how valuable FreeStyle Libre technology is for managing both diabetes and ...

Abbott’s 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care Provided by Accesswire Feb 5, 2025 1:30am ...